tradingkey.logo
搜索

Merit Medical Systems Inc

MMSI
添加自选
61.360USD
-1.200-1.92%
收盘 05/15, 16:00美东报价延迟15分钟
3.66B总市值
26.12市盈率 TTM

Merit Medical Systems Inc

61.360
-1.200-1.92%

关于 Merit Medical Systems Inc 公司

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

Merit Medical Systems Inc简介

公司代码MMSI
公司名称Merit Medical Systems Inc
上市日期Oct 22, 2090
CEOAronson (Martha Goldberg)
员工数量7400
证券类型Ordinary Share
年结日Oct 22
公司地址1600 West Merit Park Way
城市SOUTH JORDAN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编84095
电话18012531600
网址https://www.merit.com/
公司代码MMSI
上市日期Oct 22, 2090
CEOAronson (Martha Goldberg)

Merit Medical Systems Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
+0.08%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
49.79K
+4.02%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
37.10K
-33.64%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
--
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
31.47K
-11.98%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
15.07K
-23.33%
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
--
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
6.39K
+38.01%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
+0.08%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
49.79K
+4.02%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
37.10K
-33.64%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
--
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
31.47K
-11.98%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Peripheral Intervention
579.84M
38.25%
Cardiac Intervention
448.91M
29.61%
Custom Procedural Solutions
209.33M
13.81%
OEM
204.96M
13.52%
Endoscopy devices
72.86M
4.81%
地区USD
名称
营收
占比
United States
909.47M
59.99%
International
606.44M
40.01%
业务
地区
业务USD
名称
营收
占比
Peripheral Intervention
579.84M
38.25%
Cardiac Intervention
448.91M
29.61%
Custom Procedural Solutions
209.33M
13.81%
OEM
204.96M
13.52%
Endoscopy devices
72.86M
4.81%

股东统计

更新时间: 5月14日 周四
更新时间: 5月14日 周四
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.33%
Vanguard Portfolio Management, LLC
5.91%
Vanguard Capital Management, LLC
4.45%
State Street Investment Management (US)
3.74%
Conestoga Capital Advisors, LLC
3.63%
其他
68.94%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.33%
Vanguard Portfolio Management, LLC
5.91%
Vanguard Capital Management, LLC
4.45%
State Street Investment Management (US)
3.74%
Conestoga Capital Advisors, LLC
3.63%
其他
68.94%
股东类型
持股股东
占比
Investment Advisor
53.41%
Investment Advisor/Hedge Fund
31.74%
Hedge Fund
9.54%
Research Firm
5.08%
Bank and Trust
2.50%
Individual Investor
2.41%
Pension Fund
1.76%
Sovereign Wealth Fund
1.44%
Family Office
0.49%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
782
69.61M
116.70%
+4.23M
2025Q4
765
62.75M
105.84%
-4.77M
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.91M
13.34%
-62.52K
-0.78%
Sep 30, 2025
State Street Investment Management (US)
2.20M
3.71%
-19.84K
-0.89%
Sep 30, 2025
Conestoga Capital Advisors, LLC
2.19M
3.69%
-26.32K
-1.19%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
1.84M
3.11%
+23.74K
+1.30%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.45M
2.45%
+14.55K
+1.01%
Sep 30, 2025
Wellington Management Company, LLP
1.24M
2.09%
+980.82K
+377.70%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.18M
1.99%
+68.71K
+6.19%
Sep 30, 2025
Nomura Investment Management Business Trust
1.33M
2.25%
-124.75K
-8.57%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
Invesco S&P SmallCap Health Care ETF
3.18%
First Trust Indxx Medical Devices ETF
2.22%
State Street SPDR S&P Health Care Equipment ETF
1.76%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
0.71%
OneAscent Enhanced Small and Mid Cap ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
iShares S&P Small-Cap 600 Growth ETF
0.66%
Franklin US Small Cap Multifactor Index ETF
0.66%
查看更多
Invesco S&P SmallCap Health Care ETF
占比3.18%
First Trust Indxx Medical Devices ETF
占比2.22%
State Street SPDR S&P Health Care Equipment ETF
占比1.76%
Thrivent Small-Mid Cap ESG ETF
占比0.91%
Invesco S&P SmallCap Low Volatility ETF
占比0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.71%
OneAscent Enhanced Small and Mid Cap ETF
占比0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
占比0.67%
iShares S&P Small-Cap 600 Growth ETF
占比0.66%
Franklin US Small Cap Multifactor Index ETF
占比0.66%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI